CNSY Cerenome
Cerenome earnings company data as of 8:58 AM ET 10/23
- 0 of 1 EPS beats
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 29 Oct | EPS | — | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 14 Aug | EPS | -0.88 | -1.31 | Miss |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by CNSY's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $10K bought by 1 insider
- None no sales outside a trading plan
- None no planned (10b5-1) sales
-
Andrew John Hugh MacIntyre Sims CFOBuy$10K 20,000 shares at $0.5100 +42% to stakeTraded Nov 4, 2025 Filed Nov 5, 2025
Also filed in the last 12 months, not counted as buying or selling: 28 option exercises.
SEC filings
Recent issuer filings from EDGAR, 16 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 1.01,2.03,3.02,8.01,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 5.03,9.01 | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 5.07 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 3.03,5.03,8.01,9.01 | Filing Doc | |
| DEFA14A | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.